Inventor · disambiguated record
Svetlana O. Doronina
Also filed as: DORONINA SVETLANA · DORONINA SVETLANA O
32 granted patents·26 pending applications·4,117 citations·filing 2001–2023
98Inventor score
Files withSEATTLE GENETICS INC27DORONINA SVETLANA O14SEAGEN INC8PRESTA LEONARD G3PSMA DEV COMPANY LLC2
Top patents by PatentIndex Score
58 records- 0199US10808039B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2019·Granted Oct 20, 2020·18 cites·10 claims
- 0299US7994135B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Aug 9, 2011·164 cites·51 claims
- 0399US7964566B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·209 cites·60 claims
- 0499US7964567B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·134 cites·42 claims
- 0599US7851437B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Dec 14, 2010·163 cites·42 claims
- 0699US7829531B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Nov 9, 2010·199 cites·81 claims
- 0799US7745394B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 29, 2010·193 cites·44 claims
- 0899US7659241B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2003·Granted Feb 9, 2010·442 cites·78 claims
- 0999US7498298B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2004·Granted Mar 3, 2009·1.1k cites·22 claims
- 1099US6884869B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2001·Granted Apr 26, 2005·562 cites·2 claims
- 1198US8703714B2Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Granted Apr 22, 2014·59 cites·48 claims
- 1298US7750116B1Antibody drug conjugate metabolitesSEATTLE GENETICS INC·Filed 2007·Granted Jul 6, 2010·199 cites·1 claims
- 1398US7098308B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2004·Granted Aug 29, 2006·101 cites·6 claims
- 1497US8557780B2Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Granted Oct 15, 2013·32 cites·15 claims
- 1597US8343928B2Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminusSEATTLE GENETICS INC·Filed 2006·Granted Jan 1, 2013·55 cites·26 claims
- 1697US7423116B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2006·Granted Sep 9, 2008·51 cites·24 claims
- 1796US8609105B2Auristatin drug linker conjugatesSENTER PETER·Filed 2009·Granted Dec 17, 2013·92 cites·46 claims
- 1896US7256257B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2002·Granted Aug 14, 2007·69 cites·52 claims
- 1995US11510959B2Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2021·Granted Nov 29, 2022·3 cites·11 claims
- 2095US10414826B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2017·Granted Sep 17, 2019·8 cites·20 claims
- 2195US9504756B2Self-stabilizing linker conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Nov 29, 2016·26 cites·15 claims
- 2295US8288352B2Auristatins having an aminobenzoic acid unit at the N terminusDORONINA SVETLANA O·Filed 2005·Granted Oct 16, 2012·101 cites·28 claims
- 2394US8512707B2Methods of treating drug-resistant cancersDORONINA SVETLANA O·Filed 2010·Granted Aug 20, 2013·22 cites·20 claims
- 2494US8303955B2Humanized anti-CD40 antibodies and their methods of usePRESTA LEONARD G·Filed 2006·Granted Nov 6, 2012·41 cites·20 claims
- 2593US9463252B2Auristatin drug linker conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Oct 11, 2016·13 cites·43 claims
- 2693US8871720B2Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminusDORONINA SVETLANA O·Filed 2006·Granted Oct 28, 2014·29 cites·11 claims
- 2792US10933112B2Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2015·Granted Mar 2, 2021·5 cites·24 claims
- 2891US8906376B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSENTER PETER D·Filed 2010·Granted Dec 9, 2014·13 cites·20 claims
- 2984US12257281B2Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2023·Granted Mar 25, 2025·0 cites·6 claims
- 3079US9522194B2Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminusSEATTLE GENETICS INC·Filed 2014·Granted Dec 20, 2016·1 cites·12 claims
- 3178US2023132738A1Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2022·Application pending·0 cites
- 3278US2020347149A1Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 3376US10000555B2Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminusSEATTLE GENETICS INC·Filed 2012·Granted Jun 19, 2018·2 cites·30 claims
- 3471US2024216420A1Hydrophobic auristatin f compounds and conjugates thereofSEAGEN INC·Filed 2023·Application pending·0 cites
- 3569US2014220047A1Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2014·Application pending·0 cites
- 3668US2021300867A1Self-stabilizing linker conjugatesSEAGEN INC·Filed 2020·Application pending·0 cites
- 3767US2017000897A1Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 3866US2008213289A1Recombinant anti-cd30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2008·Application pending·0 cites
- 3965US2012148608A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4065US2012141509A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4165US2012141510A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4265US2012141508A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4365US2012148610A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4463US2012027784A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 4563US2012034247A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 4663US2012027783A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 4763US2012034246A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 4862US11857565B2Hydrophobic Auristatin F compounds and conjugates thereofSEAGEN INC·Filed 2019·Granted Jan 2, 2024·0 cites·12 claims
- 4961US2018154011A1Self-stabilizing linker conjugatesSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 5059US2014193405A1Humanized anti-cd40 antibodiesPRESTA LEONARD G·Filed 2014·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Svetlana O. Doronina files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →